Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

Bayer logo

Bayer

Status

Completed

Conditions

Hypothyroidism

Treatments

Drug: iodinated contrast agents

Study type

Observational

Funder types

Industry

Identifiers

NCT02766283
18614

Details and patient eligibility

About

To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice setting.

Enrollment

843 patients

Sex

All

Ages

Under 3 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

- All children age 0-3 years (inclusive) who are identified of having undergone a radiological examination with intravascular use of an iodinated contrast agent.(e.g.

contrast enhanced CT, cardioangiography)

Exclusion criteria

  • Congenital Hypothyroidism or other forms of preexisting hypothyroidism
  • Preexisting thyroid hormone replacement therapy less than three months of observation before the radiological examination (if greater than three months old)
  • Less than two weeks follow-up available after the contrast exposure.

Trial design

843 participants in 1 patient group

Iodinated contrast agents
Description:
children age 0-3 years (inclusive), who underwent a iodine contrast enhanced radiological examination.
Treatment:
Drug: iodinated contrast agents

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems